PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28392355-7 2017 VDR genotyping yielded: FokI: 57.1% FF and 38.9% Ff, BsmI: 29.8% bb and 51.5% Bb, while TaqI showed 39.4% TT and 43.4% Tt. boeravinone B 65-67 vitamin D receptor Homo sapiens 0-3 29555202-10 2018 Logistic regression analysis revealed that BB + Bb genotypes of the VDR BsmI had significantly increased the odds ratio (OR) of hypertriglyceridemia when compared with the bb genotype (OR 1.87; 95% CI 1.10-3.19, p = 0.022). boeravinone B 43-45 vitamin D receptor Homo sapiens 68-71 29555202-10 2018 Logistic regression analysis revealed that BB + Bb genotypes of the VDR BsmI had significantly increased the odds ratio (OR) of hypertriglyceridemia when compared with the bb genotype (OR 1.87; 95% CI 1.10-3.19, p = 0.022). boeravinone B 48-50 vitamin D receptor Homo sapiens 68-71 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 93-95 vitamin D receptor Homo sapiens 24-27 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 100-102 vitamin D receptor Homo sapiens 24-27 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 105-107 vitamin D receptor Homo sapiens 24-27 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 167-169 vitamin D receptor Homo sapiens 24-27 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 172-174 vitamin D receptor Homo sapiens 24-27 30058766-6 2018 In Spanish individuals, VDR BsmI gene polymorphism was associated with CRF: Recessive model (BB vs. Bb + bb): OR = 1.60, 95% CI: 1.09-2.35, P = 0.016; Additive model (BB + bb vs. Bb): OR = 1.60, 95% CI: 1.21-2.12, P = 0.001). boeravinone B 179-181 vitamin D receptor Homo sapiens 24-27 28392355-7 2017 VDR genotyping yielded: FokI: 57.1% FF and 38.9% Ff, BsmI: 29.8% bb and 51.5% Bb, while TaqI showed 39.4% TT and 43.4% Tt. boeravinone B 78-80 vitamin D receptor Homo sapiens 0-3 22213323-7 2012 Comparison of the frequencies of the VDR genotypes in sunlight-exposed vs. not sunlight-exposed skin areas revealed BB 30.1% vs. 7.1% respectively in BCCs and BB 28.1% vs. 0.0% respectively in SCCs, indicating that vitamin D signalling may be of importance for photocarcinogenesis of the skin. boeravinone B 116-118 vitamin D receptor Homo sapiens 37-40 26165414-7 2015 The BB genotype of the VDR polymorphism, BsmI, was associated with a greater decrease in FCA than the Bb/bb genotype. boeravinone B 102-104 vitamin D receptor Homo sapiens 23-26 26165414-7 2015 The BB genotype of the VDR polymorphism, BsmI, was associated with a greater decrease in FCA than the Bb/bb genotype. boeravinone B 105-107 vitamin D receptor Homo sapiens 23-26 22245613-5 2012 We conclude that the allele B (BB or Bb genotype) in vitamin D receptor gene is correlated with large amount albuminuria in the Han Chinese population with type 2 diabetes, and is probably a risk factor for early-onset diabetic nephropathy. boeravinone B 31-33 vitamin D receptor Homo sapiens 53-71 22245613-5 2012 We conclude that the allele B (BB or Bb genotype) in vitamin D receptor gene is correlated with large amount albuminuria in the Han Chinese population with type 2 diabetes, and is probably a risk factor for early-onset diabetic nephropathy. boeravinone B 37-39 vitamin D receptor Homo sapiens 53-71 28445285-6 2017 RESULTS: A significant difference was observed between VDR BsmI polymorphism and pediatric BMD levels of the lumbar spine (LS) in the corecessive model (bb vs BB + Bb: WMD = -0.23, 95% CI [-0.35, -0.11], P < 0.01). boeravinone B 153-155 vitamin D receptor Homo sapiens 55-58 28445285-6 2017 RESULTS: A significant difference was observed between VDR BsmI polymorphism and pediatric BMD levels of the lumbar spine (LS) in the corecessive model (bb vs BB + Bb: WMD = -0.23, 95% CI [-0.35, -0.11], P < 0.01). boeravinone B 159-161 vitamin D receptor Homo sapiens 55-58 28445285-6 2017 RESULTS: A significant difference was observed between VDR BsmI polymorphism and pediatric BMD levels of the lumbar spine (LS) in the corecessive model (bb vs BB + Bb: WMD = -0.23, 95% CI [-0.35, -0.11], P < 0.01). boeravinone B 164-166 vitamin D receptor Homo sapiens 55-58 22213323-7 2012 Comparison of the frequencies of the VDR genotypes in sunlight-exposed vs. not sunlight-exposed skin areas revealed BB 30.1% vs. 7.1% respectively in BCCs and BB 28.1% vs. 0.0% respectively in SCCs, indicating that vitamin D signalling may be of importance for photocarcinogenesis of the skin. boeravinone B 159-161 vitamin D receptor Homo sapiens 37-40 21703046-8 2011 An age adjusted logistic regression limited to controls and patients not receiving bisphosphonate therapy showed that higher corrected serum calcium and the VDR Bb/BB genotypes independently increased the risk of prostate cancer. boeravinone B 161-163 vitamin D receptor Homo sapiens 157-160 21703046-8 2011 An age adjusted logistic regression limited to controls and patients not receiving bisphosphonate therapy showed that higher corrected serum calcium and the VDR Bb/BB genotypes independently increased the risk of prostate cancer. boeravinone B 164-166 vitamin D receptor Homo sapiens 157-160 17557252-3 2007 RESULTS: The frequencies of the VDR Tru I genotype in the groups were: TT 68.7%, Tt 26.3%, tt 5.0%; VDR Bsm I were: BB 6.2%, Bb 52.5%, bb 41.3%; Both polymorphisms were under Hardy-Weinberg equilibrium. boeravinone B 116-118 vitamin D receptor Homo sapiens 32-35 20697762-13 2010 A predominance of Bb genotype of the VDR gene was evident in this group of postmenopausal Turkish women. boeravinone B 18-20 vitamin D receptor Homo sapiens 37-40 19887834-4 2010 RESULTS: The total allelic frequency of VDR polymorphism was: 16% BB, 49% Bb and 35% bb. boeravinone B 66-68 vitamin D receptor Homo sapiens 40-43 19887834-4 2010 RESULTS: The total allelic frequency of VDR polymorphism was: 16% BB, 49% Bb and 35% bb. boeravinone B 74-76 vitamin D receptor Homo sapiens 40-43 19887834-4 2010 RESULTS: The total allelic frequency of VDR polymorphism was: 16% BB, 49% Bb and 35% bb. boeravinone B 85-87 vitamin D receptor Homo sapiens 40-43 18769790-9 2008 The prevalence of these VDR gene polymorphisms in women with fractures were 16% BB, 69% Bb, 15% bb for Bsm-l; 30% AA, 46% Aa, 14% aa for Apa-1; 17% TT, 34 Tt, 8% tt for Taq-1 and 43%FF, 41% Ff, 16% ff for Fok-1. boeravinone B 80-82 vitamin D receptor Homo sapiens 24-27 18769790-9 2008 The prevalence of these VDR gene polymorphisms in women with fractures were 16% BB, 69% Bb, 15% bb for Bsm-l; 30% AA, 46% Aa, 14% aa for Apa-1; 17% TT, 34 Tt, 8% tt for Taq-1 and 43%FF, 41% Ff, 16% ff for Fok-1. boeravinone B 88-90 vitamin D receptor Homo sapiens 24-27 20473502-6 2010 The distribution of VDR genotyping in patients with SLE was 23.3% for BB, 60% for Bb and 16.7% for bb and in the control group was 33.3% for BB, 46.7% for Bb and 20% for bb (P = 0.334). boeravinone B 70-72 vitamin D receptor Homo sapiens 20-23 20473502-6 2010 The distribution of VDR genotyping in patients with SLE was 23.3% for BB, 60% for Bb and 16.7% for bb and in the control group was 33.3% for BB, 46.7% for Bb and 20% for bb (P = 0.334). boeravinone B 82-84 vitamin D receptor Homo sapiens 20-23 20473502-6 2010 The distribution of VDR genotyping in patients with SLE was 23.3% for BB, 60% for Bb and 16.7% for bb and in the control group was 33.3% for BB, 46.7% for Bb and 20% for bb (P = 0.334). boeravinone B 99-101 vitamin D receptor Homo sapiens 20-23 17557252-3 2007 RESULTS: The frequencies of the VDR Tru I genotype in the groups were: TT 68.7%, Tt 26.3%, tt 5.0%; VDR Bsm I were: BB 6.2%, Bb 52.5%, bb 41.3%; Both polymorphisms were under Hardy-Weinberg equilibrium. boeravinone B 116-118 vitamin D receptor Homo sapiens 100-103 17557252-3 2007 RESULTS: The frequencies of the VDR Tru I genotype in the groups were: TT 68.7%, Tt 26.3%, tt 5.0%; VDR Bsm I were: BB 6.2%, Bb 52.5%, bb 41.3%; Both polymorphisms were under Hardy-Weinberg equilibrium. boeravinone B 125-127 vitamin D receptor Homo sapiens 32-35 17557252-3 2007 RESULTS: The frequencies of the VDR Tru I genotype in the groups were: TT 68.7%, Tt 26.3%, tt 5.0%; VDR Bsm I were: BB 6.2%, Bb 52.5%, bb 41.3%; Both polymorphisms were under Hardy-Weinberg equilibrium. boeravinone B 135-137 vitamin D receptor Homo sapiens 32-35 17202743-7 2007 The VDR polymorphisms among cases (BB 3%, Bb 18%, bb 80%; AA 15%, Aa 38%, aa 47%; and TT 81%, Tt 17%, tt 3%) did not differ significantly from those among controls (BB 1%, Bb 13%, bb 86%; AA 16%, Aa 46%, aa 38%; and TT 86%, Tt 13%, tt 1%). boeravinone B 42-44 vitamin D receptor Homo sapiens 4-7 17202743-7 2007 The VDR polymorphisms among cases (BB 3%, Bb 18%, bb 80%; AA 15%, Aa 38%, aa 47%; and TT 81%, Tt 17%, tt 3%) did not differ significantly from those among controls (BB 1%, Bb 13%, bb 86%; AA 16%, Aa 46%, aa 38%; and TT 86%, Tt 13%, tt 1%). boeravinone B 50-52 vitamin D receptor Homo sapiens 4-7 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 27-29 vitamin D receptor Homo sapiens 0-3 16507161-5 2006 The distribution of VDR genotyping in patients with SLE was 1.9% for BB (non-excisable allele homozygote), 21.78% for Bb (heterozygote), and 76.23% for bb (excisable allele homozygote). boeravinone B 69-71 vitamin D receptor Homo sapiens 20-23 18336098-14 2007 The distribution of VDR alleles in patients with urolithiasis was similar to controls, although after grouping genotypes, a lower distribution of BB and tt polymorphisms were observed in patients suffering from urolithiasis. boeravinone B 146-148 vitamin D receptor Homo sapiens 20-23 16507161-6 2006 The distribution of VDR genotyping in the control group was 1.03% for BB, 15.98% for Bb, and 82.99% for bb. boeravinone B 70-72 vitamin D receptor Homo sapiens 20-23 16507161-6 2006 The distribution of VDR genotyping in the control group was 1.03% for BB, 15.98% for Bb, and 82.99% for bb. boeravinone B 85-87 vitamin D receptor Homo sapiens 20-23 16507161-6 2006 The distribution of VDR genotyping in the control group was 1.03% for BB, 15.98% for Bb, and 82.99% for bb. boeravinone B 104-106 vitamin D receptor Homo sapiens 20-23 15225773-7 2004 The prevalence of the three BsmI VDR genotypes was 19.1, 44.9 and 36.0% for BB, Bb and bb, respectively. boeravinone B 76-78 vitamin D receptor Homo sapiens 33-36 15225773-7 2004 The prevalence of the three BsmI VDR genotypes was 19.1, 44.9 and 36.0% for BB, Bb and bb, respectively. boeravinone B 80-82 vitamin D receptor Homo sapiens 33-36 15225773-7 2004 The prevalence of the three BsmI VDR genotypes was 19.1, 44.9 and 36.0% for BB, Bb and bb, respectively. boeravinone B 87-89 vitamin D receptor Homo sapiens 33-36 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 38-40 vitamin D receptor Homo sapiens 0-3 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 53-55 vitamin D receptor Homo sapiens 0-3 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 96-98 vitamin D receptor Homo sapiens 0-3 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 107-109 vitamin D receptor Homo sapiens 0-3 14691685-4 2004 VDR allelic variants were: BB, 31.6%; Bb, 44.7%; and bb, 23.7% in the osteomalacia patients and BB, 19.4%; Bb, 61.3%; and bb, 19.4% in the controls. boeravinone B 122-124 vitamin D receptor Homo sapiens 0-3 12786678-9 2003 RESULTS: In young males with low physical activity (n = 752) gene carriers with the VDR genotype BB (n = 137) have significantly (P < 0.001) higher levels of fasting glucose (5.61 +/- 0.49 mmol/l) than gene carriers with the genotype Bb (n = 370; 5.44 +/- 0.44 mmol/l) or bb (n = 245; 5.38 +/- 0.44 mmol/l). boeravinone B 275-277 vitamin D receptor Homo sapiens 84-87 12958689-6 2003 Correlations were found between VDR genotypes and BMD at lumbar spine L2-L4, (ss versus LL, P = 0.03 and BB versus bb, P = 0.02, respectively), with a similar pattern concerning total hip (ss versus LL, P = 0.12 and BB versus bb, P = 0.16 respectively). boeravinone B 105-107 vitamin D receptor Homo sapiens 32-35 12958689-6 2003 Correlations were found between VDR genotypes and BMD at lumbar spine L2-L4, (ss versus LL, P = 0.03 and BB versus bb, P = 0.02, respectively), with a similar pattern concerning total hip (ss versus LL, P = 0.12 and BB versus bb, P = 0.16 respectively). boeravinone B 115-117 vitamin D receptor Homo sapiens 32-35 12958689-6 2003 Correlations were found between VDR genotypes and BMD at lumbar spine L2-L4, (ss versus LL, P = 0.03 and BB versus bb, P = 0.02, respectively), with a similar pattern concerning total hip (ss versus LL, P = 0.12 and BB versus bb, P = 0.16 respectively). boeravinone B 216-218 vitamin D receptor Homo sapiens 32-35 12958689-6 2003 Correlations were found between VDR genotypes and BMD at lumbar spine L2-L4, (ss versus LL, P = 0.03 and BB versus bb, P = 0.02, respectively), with a similar pattern concerning total hip (ss versus LL, P = 0.12 and BB versus bb, P = 0.16 respectively). boeravinone B 226-228 vitamin D receptor Homo sapiens 32-35 12958689-7 2003 After corrections for age, height, fat and lean mass, the VDR BsmI genotype was still associated to BMD at the lumbar spine (BB versus bb, P = 0.03). boeravinone B 125-127 vitamin D receptor Homo sapiens 58-61 12958689-7 2003 After corrections for age, height, fat and lean mass, the VDR BsmI genotype was still associated to BMD at the lumbar spine (BB versus bb, P = 0.03). boeravinone B 135-137 vitamin D receptor Homo sapiens 58-61 12649542-0 2003 BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients. boeravinone B 0-2 vitamin D receptor Homo sapiens 19-37 10666492-4 2000 The frequency of VDR alleles was as follows: bb (20.9%), Bb (60.5%), and BB (18.6%), and that of ER alleles was pp (39.5%), Pp (51.2%), and PP (9.3%). boeravinone B 45-47 vitamin D receptor Homo sapiens 17-20 11392075-3 2001 In subjects exhibiting XX genotype of the estrogen receptor gene or bb genotype of the vitamin D receptor gene, erbB-2 expression was significantly lower compared to those with xx, Xx or BB, Bb (6/56 and 11/56 vs. 31/56 and 26/56; p = 0.0043 and 0.041). boeravinone B 191-193 vitamin D receptor Homo sapiens 87-105 11335187-5 2001 In linear regression models to control for covariates, VDR genotype (BB and Bb vs. bb), blood lead, tibia lead, and DMSA-chelatable lead were all positive predictors of systolic blood pressure. boeravinone B 69-71 vitamin D receptor Homo sapiens 55-58 11335187-5 2001 In linear regression models to control for covariates, VDR genotype (BB and Bb vs. bb), blood lead, tibia lead, and DMSA-chelatable lead were all positive predictors of systolic blood pressure. boeravinone B 76-78 vitamin D receptor Homo sapiens 55-58 11335187-5 2001 In linear regression models to control for covariates, VDR genotype (BB and Bb vs. bb), blood lead, tibia lead, and DMSA-chelatable lead were all positive predictors of systolic blood pressure. boeravinone B 83-85 vitamin D receptor Homo sapiens 55-58 11729524-5 2001 RESULTS: The respective frequencies of VDR genotypes were BB 18.6%, Bb 27.8% and bb 53.6%. boeravinone B 68-70 vitamin D receptor Homo sapiens 39-42 11461072-5 2001 The VDR polymorphism Bsm I, an intronic 3" gene variant, was significantly associated with increased breast cancer risk: odds ratio bb vs BB genotype = 2.32 (95% CI, 1.23-4.39). boeravinone B 132-134 vitamin D receptor Homo sapiens 4-7 11461072-5 2001 The VDR polymorphism Bsm I, an intronic 3" gene variant, was significantly associated with increased breast cancer risk: odds ratio bb vs BB genotype = 2.32 (95% CI, 1.23-4.39). boeravinone B 138-140 vitamin D receptor Homo sapiens 4-7 10706524-8 2000 In a multiple linear regression model of tibial lead concentrations, the VDR genotype modified the relation between age and tibial lead concentrations; subjects with the B allele had larger increases in tibial lead concentrations with increasing age (0.37, 0.48, and 0.67 microg/g per year of age in subjects with bb, Bb, and BB, respectively; the adjusted p-value for trend in slopes = 0.04). boeravinone B 314-316 vitamin D receptor Homo sapiens 73-76 10706524-8 2000 In a multiple linear regression model of tibial lead concentrations, the VDR genotype modified the relation between age and tibial lead concentrations; subjects with the B allele had larger increases in tibial lead concentrations with increasing age (0.37, 0.48, and 0.67 microg/g per year of age in subjects with bb, Bb, and BB, respectively; the adjusted p-value for trend in slopes = 0.04). boeravinone B 318-320 vitamin D receptor Homo sapiens 73-76 10706524-8 2000 In a multiple linear regression model of tibial lead concentrations, the VDR genotype modified the relation between age and tibial lead concentrations; subjects with the B allele had larger increases in tibial lead concentrations with increasing age (0.37, 0.48, and 0.67 microg/g per year of age in subjects with bb, Bb, and BB, respectively; the adjusted p-value for trend in slopes = 0.04). boeravinone B 326-328 vitamin D receptor Homo sapiens 73-76 10666492-4 2000 The frequency of VDR alleles was as follows: bb (20.9%), Bb (60.5%), and BB (18.6%), and that of ER alleles was pp (39.5%), Pp (51.2%), and PP (9.3%). boeravinone B 57-59 vitamin D receptor Homo sapiens 17-20 10666492-4 2000 The frequency of VDR alleles was as follows: bb (20.9%), Bb (60.5%), and BB (18.6%), and that of ER alleles was pp (39.5%), Pp (51.2%), and PP (9.3%). boeravinone B 73-75 vitamin D receptor Homo sapiens 17-20 9719169-5 1998 RESULTS: VDR genotype BB, Bb and bb were found in 27, 49 and 24% of patients. boeravinone B 33-35 vitamin D receptor Homo sapiens 9-12 10813109-7 2000 The relative distribution of VDR genotypes and alleles in the Slovenian population was 18.6:57.8:23.6% for BB:Bb:bb, respectively. boeravinone B 107-109 vitamin D receptor Homo sapiens 29-32 10813109-7 2000 The relative distribution of VDR genotypes and alleles in the Slovenian population was 18.6:57.8:23.6% for BB:Bb:bb, respectively. boeravinone B 110-112 vitamin D receptor Homo sapiens 29-32 10813109-7 2000 The relative distribution of VDR genotypes and alleles in the Slovenian population was 18.6:57.8:23.6% for BB:Bb:bb, respectively. boeravinone B 113-115 vitamin D receptor Homo sapiens 29-32 10692979-7 1999 With respect to VDR genotype, a significantly higher decrease in osteocalcin level was observed in bb as compared with BB subjects. boeravinone B 99-101 vitamin D receptor Homo sapiens 16-19 10692979-7 1999 With respect to VDR genotype, a significantly higher decrease in osteocalcin level was observed in bb as compared with BB subjects. boeravinone B 119-121 vitamin D receptor Homo sapiens 16-19 10101442-10 1998 Results from this study suggest that faster bone mineral loss and more exaggerated disturbances of vitamin D metabolism are present in haemodialyzed uraemic patients with BB than bb genotype of VDR. boeravinone B 179-181 vitamin D receptor Homo sapiens 194-197 9844148-9 1998 The patients with the BB pattern of VDR genotype were characterized by the lowest PTH levels both at time of transplantation and after stabilization, and lower set point values than patients with Bb and bb patterns. boeravinone B 22-24 vitamin D receptor Homo sapiens 36-39 9844148-9 1998 The patients with the BB pattern of VDR genotype were characterized by the lowest PTH levels both at time of transplantation and after stabilization, and lower set point values than patients with Bb and bb patterns. boeravinone B 196-198 vitamin D receptor Homo sapiens 36-39 9844148-9 1998 The patients with the BB pattern of VDR genotype were characterized by the lowest PTH levels both at time of transplantation and after stabilization, and lower set point values than patients with Bb and bb patterns. boeravinone B 203-205 vitamin D receptor Homo sapiens 36-39 9610787-5 1998 Among controls, the BB genotype was significantly associated with higher 1,25-dihydroxyvitamin D (median = 36.2 pg/ml for the BB versus 33.9 pg/ml for the bb genotype; P = 0.02), suggesting an association of the VDR polymorphisms with VDR function. boeravinone B 20-22 vitamin D receptor Homo sapiens 212-215 9610787-5 1998 Among controls, the BB genotype was significantly associated with higher 1,25-dihydroxyvitamin D (median = 36.2 pg/ml for the BB versus 33.9 pg/ml for the bb genotype; P = 0.02), suggesting an association of the VDR polymorphisms with VDR function. boeravinone B 20-22 vitamin D receptor Homo sapiens 235-238 8889857-8 1996 The association of VDR genotype with BMD at the femoral neck appeared to be modified by calcium intake (BB and Bb: 0.797 +/- 0.11 g/cm2 vs. 0.844 +/- 0.11 g/cm2, interaction term, p = 0.06) for low (< 1036 mg/day) and high (> or = 1036 mg/day; upper quartile) calcium intakes, respectively. boeravinone B 104-106 vitamin D receptor Homo sapiens 19-22 8889857-8 1996 The association of VDR genotype with BMD at the femoral neck appeared to be modified by calcium intake (BB and Bb: 0.797 +/- 0.11 g/cm2 vs. 0.844 +/- 0.11 g/cm2, interaction term, p = 0.06) for low (< 1036 mg/day) and high (> or = 1036 mg/day; upper quartile) calcium intakes, respectively. boeravinone B 111-113 vitamin D receptor Homo sapiens 19-22 8845602-6 1996 The frequency distribution of the VDR genotype was: bb, 20.6%; Bb, 39.1%; and BB, 40.2%. boeravinone B 52-54 vitamin D receptor Homo sapiens 34-37 8845602-6 1996 The frequency distribution of the VDR genotype was: bb, 20.6%; Bb, 39.1%; and BB, 40.2%. boeravinone B 63-65 vitamin D receptor Homo sapiens 34-37 8845602-6 1996 The frequency distribution of the VDR genotype was: bb, 20.6%; Bb, 39.1%; and BB, 40.2%. boeravinone B 78-80 vitamin D receptor Homo sapiens 34-37